Neurons and glial cells

Published on 13/06/2015 by admin

Filed under Basic Science

Last modified 22/04/2025

Print this page

rate 1 star rate 2 star rate 3 star rate 4 star rate 5 star
Your rating: none, Average: 5 (1 votes)

This article have been viewed 7177 times

Neurons and glial cells

Nerve cells

The basic structure of the neuron has been outlined in Chapter 1. It was also shown how nerve cells can be classified based upon the type of information that they transmit (afferent, efferent, interneuron) or by the number of processes that they have (unipolar, bipolar, multipolar). Neuronal excitability, impulse conduction and synaptic transmission are discussed in Chapters 6 and 7.

Cortical neurons

The cerebral cortex contains more than 50 billion neurons arranged in horizontal layers or laminae. Although cortical neurons vary enormously in size and shape, there are two major types (discussed below).

Pyramidal and granule cells (Fig. 5.1A & B)

Pyramidal cells have large, pyramid-shaped cell bodies that range from 20–120 µm in diameter. They are excitatory neurons that have numerous apical and basal dendrites and a single axon that projects out of the cortex. Pyramidal cells are particularly prominent in motor and premotor areas. Granule cells (or stellate cells) are star-shaped multipolar neurons that have short axons and make local synaptic contacts, tending to be enriched in sensory cortices. They are much smaller than pyramidal cells, with a typical diameter of less than 20 µm, and may be excitatory or inhibitory. The cerebellar cortex also contains two main types of nerve cell: granule cells (similar to those in the cerebral cortex) and Purkinje cells (large efferent neurons, equivalent to cortical pyramidal cells; see Fig. 5.1C).

Cortical lamination

More than 90% of the cerebral cortex has a characteristic six-layered structure that appeared with the evolution of the mammalian brain (Fig. 5.2). For this reason it is referred to as neocortex (Greek: neos, new). Although the same six layers can be identified in all neocortical regions at some stage of development, they are not always present in the mature brain. For instance, the motor and premotor areas of the frontal neocortex are referred to as agranular cortex since they have lost their internal granule cell layer.

Different types of cortex

The cerebral cortex can be divided into more than fifty Brodmann areas based on subtle differences in the cortical structure (referred to as cytoarchitectonics) but there are three major cortical types (Fig. 5.3):

The majority of the ‘non-neocortical’ regions belong to the limbic lobe and are primarily concerned with emotion, memory and olfaction (the sense of smell). The term paralimbic cortex is used to describe non-neocortical regions outside of the limbic lobe proper, including the posterior orbital cortex, anterior insula and temporal pole.

Features of the neuron

Nerve cells have many features in common with other cells, together with a number of unique structural and functional components.

Dendritic spines

The dendrites of many neurons are studded with thousands of tiny, mushroom-shaped dendritic spines (Fig. 5.4). These include the medium spiny neurons that make up 95% of cells in the basal ganglia. In the cerebral cortex, all pyramidal cells have dendritic spines, whereas stellate cells may be spiny or smooth. Each dendritic spine is the site of an incoming excitatory synapse and a typical cortical pyramidal neuron has more than 10,000 spines. They are dynamic structures that can form, change shape or disappear altogether and are thought to be important in synaptic plasticity (Greek: plastikos, able to be moulded) and learning. Long-term memories may be mediated by the growth of new spines or the strengthening and enlargement of existing ones.

Subcellular organelles

The neuronal cell body or soma (Greek: soma, body) contains the same organelles found in other cell types (Fig. 5.5) but the machinery for protein synthesis and gene transcription is particularly prominent (Fig. 5.6A). The perinuclear cytoplasm or perikaryon (Greek: peri, around; cyton, kernel) contains a well-developed network of rough endoplasmic reticulum, often arranged in clumps called Nissl bodies. The Golgi apparatus is also prominent and is the site of post-translational modification and sorting of proteins including ion channels, neurotransmitter receptors and membrane ion pumps.

Vesicles

Neurons contain various types of membrane-bound vesicle. Neurotransmitters and neuropeptides are stored in the axon terminal (prior to release) within synaptic vesicles (see Ch. 7). Coated vesicles are derived from internalization of membrane constituents and macromolecules that have been taken up from the extracellular fluid by receptor-mediated endocytosis.

The neuronal cytoskeleton

All cells have a cytoskeleton composed of an internal framework of fibrillar proteins, that gives each cell its characteristic shape. This molecular scaffold is particularly important in process-bearing cells such as neurons and glia, which have a complex structure. The cytoskeleton is also involved in the transport of materials between intracellular compartments (see below). The main components include microtubules, neurofilaments and microfilaments (Fig. 5.7).

Axonal transport

The biological machinery for protein synthesis (in the neuronal cell body) may be quite a distance from the axon terminal. For this reason, the neuron has a fast axonal transport mechanism for membrane-bound materials and organelles:

Fast axonal transport is mediated by a group of molecular motor proteins called kinesins (for anterograde transport) and dyneins (for retrograde transport). These proteins are ATPases that carry vesicle-bound cargo along microtubule tracks that run the length of the axon. Retrograde axonal transport is involved in some central nervous system viral infections (Clinical Box 5.1).

Small molecular components and soluble enzymes that are not membrane-bound move towards the axon terminal via slow anterograde axonal transport. This is also referred to as axoplasmic flow and proceeds at a rate of 1–5 mm per day. The mechanism is not clear.

Astrocytes

Astrocytes are process-bearing cells with a stellate morphology (Greek: astron, star) and are the main support cells of the central nervous system (CNS). Astrocytic processes have specialized structures called end-feet that make contact with neurons and capillaries (Fig. 5.8A).

Astrocyte functions

Astrocytes contribute to homeostasis, helping to maintain a constant internal environment for neurons (e.g. by removing excess potassium ions and glutamate from the extracellular fluid). They are also involved in the response to injury, releasing cytokines and growth factors and multiplying to form a glial scar (see Ch. 8). Some other key roles are discussed in more detail below.

The blood–brain barrier (Fig. 5.8B)

Endothelial cells in CNS capillaries have tight junctions that restrict solute exchange between the brain and bloodstream. This is normally referred to as the blood–brain barrier (BBB), but is more accurately described as a blood–CNS barrier since it is also present in the spinal cord and retina. A similar arrangement in the choroid plexuses of the ventricles creates a blood–CSF barrier.

The blood–brain barrier is maintained by astrocytes via an inductive interaction between perivascular end-feet and CNS capillaries. Cerebral capillaries also lack fenestrations and contain few pinocytotic vesicles, so that transcellular flux is similarly limited. The blood–brain barrier effectively blocks charged or polar molecules, but lipid-soluble substances (including many centrally-active drugs and anaesthetic agents) pass relatively freely.

The existence of the blood–brain barrier requires that the brain has a number of carrier-mediated transport mechanisms for the uptake of essential nutrients. Glucose is imported by a specific glucose transporter (GLUT-1) which is present on the surface of endothelial cells. Large neutral amino acids such as phenylalanine also have a specific transporter protein, and drugs used in the treatment of Parkinson’s disease gain access to the brain via the same transporter (Ch. 13).

Energy metabolism

Astrocytes are intimately involved in brain energy metabolism. In addition to storing a modest amount of glycogen they also take up glucose and pre-digest it to lactate (via the glycolytic pathway). The lactate is then exported to the extracellular compartment where it is taken up by neurons as their principal source of energy.

Following activity at an excitatory (glutamatergic) synapse, perisynaptic astrocytes take up some of the released glutamate via specific transporters. These membrane pumps import sodium ions (Na+) together with glutamate, thereby increasing the sodium ion concentration in the perisynaptic astrocytes. This in turn stimulates the sodium–potassium exchange pump (Na+/K+-ATPase) which promotes glycolysis. More lactate is thus produced, which can be made available to the metabolically active neurons. This is an example of metabolic coupling between neurons and astrocytes, which is relevant in certain neurological conditions (Clinical Box 5.2).

The glutamate–glutamine shuttle (Fig. 5.9)

One of the roles of astrocytes is to help clear glutamate from the extracellular space. Astrocytes metabolize glutamate to glutamine by the enzyme glutamine synthetase. This consumes ammonia, which provides the amine group (–NH2) of glutamine and serves an important metabolic role by detoxifying this nitrogenous waste product. Glutamine is released into the extracellular fluid where it is taken up by neurons and hydrolysed by the mitochondrial enzyme glutaminase, converting it back to glutamate.

Oligodendrocytes and Schwann cells

Oligodendrocytes are small, rounded cells with relatively few cytoplasmic processes (Greek: oligo, few). They are numerous in the CNS white matter and are responsible for investing central axons with a lipid-rich myelin sheath. Each oligodendrocyte makes contact with up to a dozen neighbouring axons and provides a single segment of myelin to each (Fig. 5.10). In the peripheral nervous system, Schwann cells are responsible for myelination, but each cell makes contact with only one axon and provides a single segment of myelin. Both types of cell secrete growth factors and provide trophic support to the axons that they invest.

Myelination

Myelin consists of multiple concentric layers of glial cell membrane (Figs 5.11A and 5.12). A small amount of cytoplasm is initially present between the layers but this is gradually squeezed out as the myelin is compacted and the lipid bilayers fuse. Axons are myelinated in 1 mm segments interrupted by microscopic gaps called nodes of Ranvier, at which point the axon is in direct contact with the extracellular fluid. The myelinated segments are called internodes (Latin: inter-, between). Some small-diameter axons do not have a myelin sheath, but are contained within an infolding of Schwann cell membrane, along with several other non-myelinated axons (see Fig. 5.11B).

Composition of myelin

CNS myelin is rich in myelin basic protein (MBP) and proteolipid protein (PLP). The major protein component of peripheral myelin (around 80%) is myelin protein zero (P0). This is a member of the immunoglobulin superfamily and is essential for compaction of adjacent myelin lamellae which enables axons to be tightly wrapped. Another component is peripheral myelin protein 22 (PMP-22) which has been implicated in some heritable forms of peripheral neuropathy (Clinical Box 5.3).

Saltatory conduction

Myelination significantly increases axonal conduction velocity. This is because the nerve impulse ‘jumps’ from node to node (Latin: saltare, to leap) rather than spreading continuously along the axonal membrane (see Ch. 6). Focal disruption of the myelin sheath can lead to failure of impulse conduction in the denuded axon segments (termed conduction block) in part because of a paucity of voltage-gated sodium ion channels between the nodes of Ranvier. Conduction block is a feature of demyelinating conditions such as multiple sclerosis (Ch. 14).

Other glial cells

The most important types of glial cell other than astrocytes and oligodendrocytes are microglia and ependymal cells, which are discussed in more detail below. Others include:

Many of these cells are related to astrocytes and have similar roles. Olfactory ensheathing cells (OECs) are of particular interest because they permit new axons to grow into the mature CNS, which only normally occurs in the olfactory bulb. These cells therefore provide some hope of encouraging axonal regrowth in the CNS after brain or spinal cord injury.

Microglia

Microglia are relatively small cells (Greek: micro, small) with rod-shaped nuclei (Fig. 5.13) and are the resident phagocytes of the CNS. At rest they exist in a quiescent state and are described as ramified (entwined within the feltwork of axons and dendrites). In response to tissue damage and inflammation they transform into activated microglia which migrate to the site of injury and internalize particulate materials and microorganisms. Microglia are discussed further in Chapter 8 in the context of brain inflammation and gliosis.

Ependymal cells

Ependymal cells form a continuous epithelial sheet (the ependyma) that lines the ventricles and the central canal of the spinal cord. These cells are of glial lineage, but have many epithelial characteristics including a basement membrane, cell–cell junctions and motile cilia. The choroid plexus of each ventricle (which is responsible for the secretion of cerebrospinal fluid as an ultrafiltrate of plasma) is composed of a capillary network covered by a sheet of modified ependymal cells. These cells are connected by tight junctions, which represents a blood–CSF barrier.

Glial tumours

Intracerebral tumours can be classified as primary (arising within the brain) or secondary (metastatic tumours that have spread from another site). Secondary tumours are more common and often originate from the lung, breast or bowel. Primary CNS tumours are further classified as extrinsic or intrinsic (Fig. 5.14). Extrinsic tumours derive from the coverings of the CNS. They tend to be benign and slow-growing and include meningiomas (derived from the meninges) and peripheral nerve sheath tumours. Intrinsic tumours of the brain and spinal cord are of neuroepithelial lineage and usually show evidence of glial differentiation; for this reason they are referred to as glial tumours or gliomas.

Glial tumours are thought to arise from stem cells (which normally give rise to new neurons or glia) that have accumulated mutations enabling them to proliferate in an uncontrolled manner and to diffusely infiltrate brain tissue. The typical MRI appearances of a malignant glial tumour are shown in Fig. 5.15.

General features of gliomas

Glial tumours are relatively uncommon, with a lifetime risk of less than 1 in 200, but tend to be highly malignant and carry a poor prognosis. The presenting features are discussed in Clinical Box 5.4.

image Clinical Box 5.4:   Clinical features of brain tumours

Brain tumours act as space-occupying lesions within the cranial cavity and cause raised intracranial pressure (Ch. 9). This typically presents with headaches that tend to be worse in the morning and are exacerbated by coughing, stooping or straining. There may also be nausea, vomiting or transient visual obscurations. Some patients present with seizures or focal neurological deficits. There is often papilloedema, defined as bilateral swelling of the optic discs due to raised intracranial pressure (Fig. 5.16). Drowsiness is an ominous sign that occurs in the later stages and may precede rapid neurological deterioration.

Classification and grading

Tumour type (e.g. astrocytoma, oligodendroglioma, etc.) is determined by examining a tissue sample under the microscope. Classification is based on the growth pattern and microscopic appearance of the cells, often supplemented by immunohistochemistry (antibody labelling) to identify proteins that are typically expressed in certain types of tumour.

Tumours are also given a histological grade (from I to IV) that attempts to quantify their malignant potential (degree of biological aggressiveness) (Fig. 5.17). Grading is based on tumour architecture (pattern of growth), atypical cytology (cells and nuclei with abnormal structural features) and proliferation rate (speed of growth). Grade I and II tumours are termed benign (or low grade) whereas grade III and IV tumours are designated malignant (or high grade). In general, the prognosis is less favourable as the histological grade increases. The most common (and also the most aggressive) form of glial tumour is glioblastoma (grade IV) in which the median survival is less than 12 months.

Molecular genetics

The most useful molecular test in gliomas is assessment of 1p19q status in oligodendroglial tumours. At least 70% of oligodendrogliomas have a combined loss of chromosomal arms 1p and 19q. This is found in less than 5% of astrocytic tumours and around 40% of mixed oligo-astrocytomas. The presence of 1p19q codeletion in an oligodendroglioma is an independent prognostic indicator and predicts a robust response to chemotherapy. Studies show that 100% of patients with 1p19q co-deletion show a good response to PCV chemotherapy (procarbazine, CCNU, vincristine).

Another useful molecular signature is mutation in one of the two isoforms of the Kreb’s cycle enzyme isocitrate dehydrogenase (IDH1/IDH2). This is present in 80% of low-grade astrocytic and oligodendroglial tumours and predicts a more favourable outcome. In glioblastoma, the presence of a particular molecular genetic change predicts response to chemotherapy (Clinical Box 5.5).

Management of gliomas

Glial tumours are managed primarily by surgical resection. Oral corticosteroids (dexamethasone) help to relieve cerebral oedema and raised intracranial pressure, whereas anti-epileptic drugs can be used to control seizures. Surgery usually has one of two main aims:

Complete removal of glial tumours is usually not possible (even with extensive resection) due to their highly infiltrative nature. Surgery may also be limited by involvement of eloquent (language or motor) areas. The role of radiotherapy and chemotherapy is relatively limited in primary brain tumours, but may prolong survival by a few months in high-grade gliomas.